Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy - Maria Sibilia - Books - Birkhauser Verlag AG - 9783034600934 - January 7, 2011
In case cover and title do not match, the title is correct

Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy

Maria Sibilia

Price
S$ 245

Ordered from remote warehouse

Expected delivery Dec 5 - 18
Christmas presents can be returned until 31 January

Our customers say:

14-day return policy in accordance with European consumer protection law
Top ranking on Trustpilot
Add to your iMusic wish list

Drugs for HER-2-positive Breast Cancer - Milestones in Drug Therapy

Growth factor receptors have long been known to drive malignant transformation and cancer progression. The epidermal growth factor receptor (EGFR, ErbB, HER) system is likely the best described membrane receptor tyrosine kinase family in malignant tumors.

120 pages, biography

Media Books     Hardcover Book   (Book with hard spine and cover)
Released January 7, 2011
ISBN13 9783034600934
Publishers Birkhauser Verlag AG
Pages 110
Dimensions 164 × 244 × 14 mm   ·   299 g
Language French  
Editor Bartsch, Rupert
Editor Grunt, Thomas W.
Editor Sibilia, Maria
Editor Zielinski, Christoph C.

See all of Maria Sibilia ( e.g. Hardcover Book )